Kürşad AYDIN, Ayşe SERDAROĞLU, Ebru ARHAN, Tuğba HİRFANOĞLU, Cengiz HAVALI, Yılmaz AKBAŞ, Leman TEKİN ORGUN, Zeynep ÖZTÜRK

Ciddi Bir Yan Etki Olmadan Yüksek Doz Levetirasetam Alan İki Olgu

Yüksek doz levetirasetam alımı olan 2 vaka sunulmuştur. İlk vaka; 3 yaşında kız hasta, 1 aydır levetirasetamı 115 mg/kg/gün dozda almıştı. 2. vaka olan 3 aylık kız hasta ise levetirasetamı 300 mg/kg/gün dozda 1 ay süreyle kullanmıştı. İzlemlerinde hastalarımızda yüksek doz kullanıma rağmen herhangi bir ciddi yan etki gözlenmedi.

Two Cases of Levetiracetam Overdose Without Any Serious Side Effects

We present two pediatric cases of levetiracetam overdose. The first case wasa 3-year-old girl who was, by her family, accidentally given levetiracetam at115 mg/kg/day for one-month duration. The second case, a 3-month-old girlwho accidentally used 300 mg/kg/day dose about one month. We didn'tobserve remarkable severe side effects in our patients.

PDF

___

Glauser TA, Pellock JM, Bebin EM, Fountain NB, Ritter FJ, Jensen CM, et al. Efficacy and safety of levetiracetam in children with partial seizures: an openlabel trial. Epilepsia. 2002;43:518-24.
Perry MS, Benatar M. Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review. Epilepsia. 2007;48:1123-7.
Chayasirisobhon S, Chayasirisobhon WV, Tsay CC. Acute levetiracetam overdose presented with mild adverse events. Acta neurologica Taiwanica. 2010;19:292-5.
Beran RG, Berkovic SF, Black AB, Danta G, Hiersemenzel R, Schapel GJ, et al. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study. Epilepsy research. 2005;63:1-9.
Luszczki JJ, Andres MM, Czuczwar P, Cioczek-Czuczwar A, Wojcik-Cwikla J, Ratnaraj N, et al. Levetiracetam selectively potentiates the acute neurotoxic effects of topiramate and carbamazepine in the rotarod test in mice. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 2005;15:609-16.
Patsalos PN. Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacology & therapeutics. 2000;85:77-85.
Barrueto F, Jr., Williams K, Howland MA, Hoffman RS, Nelson LS. A case of levetiracetam (Keppra) poisoning with clinical and toxicokinetic data. Journal of toxicology Clinical toxicology. 2002;40:881-4.
Ozkale Y, Ozkale M, Saygi S, Erol I. Long-term accidental overdose of levetiracetam in an infant. Journal of child neurology. 2014;29:959-61.
Diaz A, Deliz B, Benbadis SR. The use of newer antiepileptic drugs in patients with renal failure. Expert review of neurotherapeutics. 2012;12:99- 105.
Bodmer M, Monte AA, Kokko J, Yin S. Safety of non-therapeutic levetiracetam ingestions--a poison center based study. Pharmacoepidemiology and drug safety. 2011;20:366-9.